← Leaderboards
Cigall Kadoch
Dana-Farber Cancer Inst
$10,191,824
Attributed
$12,477,011
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $9.1M · FY2014–25$10M$7.5M$5M$2.5M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$18,314,773 · 7
By mechanism
U54$9,114,414 · 3
R01$6,605,359 · 3
DP2$2,595,000 · 1
Top collaborators
- Tom W Muir5 shared
- E. John Wherry2 shared
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- Xiaofeng Wang$2,865,626
- Alex Kentsis$10,070,317
- Stephanie Dougan$3,590,414
- Lorelei Mucci$13,743,245
- Steven Thomas Poynter$122,773
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsBiologyChromatinComplexGenesRegulationGenome-WideBindingNovel Therapeutic InterventionOncogenicChromatin Remodeling FactorMutateGenomicsNucleosomesCellsGene ExpressionBiologicalSiteCell LineMutationStructureHistonesMaintenanceSynovial Sarcoma
Grant awards (19)
Structure-activity relationships governing mammalian SWI/SNF chromatin remodeling activity as a function of chromatin state$690,368
R01 · FY2025 · CA · contact PI
Structure-activity relationships governing mammalian SWI/SNF chromatin remodeling activity as a function of chromatin state$655,849
R01 · FY2024 · CA · contact PI
Structure-activity relationships governing mammalian SWI/SNF chromatin remodeling activity as a function of chromatin state$676,560
R01 · FY2023 · CA · contact PI
Cancer-Specific Targeting and Function of Mammalian SWI/SNF (BAF) Chromatin Remodeling Complexes$395,669
R01 · FY2023 · CA · contact PI
The Center for Synovial Sarcoma Biology and Therapeutics$200,000
U54 · FY2023 · CA · contact PI
Structure-activity relationships governing mammalian SWI/SNF chromatin remodeling activity as a function of chromatin state$676,560
R01 · FY2022 · CA · contact PI
Cancer-Specific Targeting and Function of Mammalian SWI/SNF (BAF) Chromatin Remodeling Complexes$395,669
R01 · FY2022 · CA · contact PI
The Center for Synovial Sarcoma Biology and Therapeutics$194,910
U54 · FY2022 · CA · contact PI
Structure-activity relationships governing mammalian SWI/SNF chromatin remodeling activity as a function of chromatin state$709,868
R01 · FY2021 · CA · contact PI
Cancer-Specific Targeting and Function of Mammalian SWI/SNF (BAF) Chromatin Remodeling Complexes$436,159
R01 · FY2021 · CA · contact PI
The Center for Synovial Sarcoma Biology and Therapeutics$191,200
U54 · FY2021 · CA · contact PI
Cancer-Specific Targeting and Function of Mammalian SWI/SNF (BAF) Chromatin Remodeling Complexes$403,744
R01 · FY2020 · CA · contact PI
Testing the role of BATF as a pioneer transcription factor in effector T cells$582,513
R01 · FY2019 · AI · contact PI
Cancer-Specific Targeting and Function of Mammalian SWI/SNF (BAF) Chromatin Remodeling Complexes$403,744
R01 · FY2019 · CA · contact PI
The Center for Synovial Sarcoma Biology and Therapeutics$5,251,652
U54 · FY2018 · CA · contact PI
SS18-SSX-mediated Hijacking of mSWI/SNF (BAF) Complexes: Mechanisms and Functional Dependencies$2,647,500
U54 · FY2018 · CA · contact PI
Administrative Core (C1)$629,152
U54 · FY2018 · CA · contact PI
Testing the role of BATF as a pioneer transcription factor in effector T cells$578,656
R01 · FY2018 · AI · contact PI
Reversing Oncogenic BAF Complex Structure & Function: New Therapeutic Approaches$2,595,000
DP2 · FY2014 · CA · contact PI